Anita Z. Graham
Known title: EVP, CHROCIK: 0001206814
Associated companies
Transaction History
| LH | ▲ Buy | Grant | 6,604 | $0 | 3/26/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 2,879 | $773K | 3/26/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 356 | — | 2/11/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 109 | $32K | 2/11/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 112 | $31K | 2/9/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 367 | — | 2/7/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 327 | — | 2/6/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 119 | $33K | 2/6/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 119 | $29K | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 369 | — | 2/7/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 118 | $29K | 2/6/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 326 | — | 2/6/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 107 | $24K | 2/7/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 369 | — | 2/7/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Labcorp to Acquire OPKO Health's BioReference Assets for $722M
Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.
Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.